Terms: = Leukemia AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Treatment
82 results:
1. Systems Biology for Drug Target Discovery in Acute Myeloid leukemia.
Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Zgoda V
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731835
[TBL] [Abstract] [Full Text] [Related]
2. TPEN selectively eliminates lymphoblastic B cells from bone marrow pediatric acute lymphoblastic leukemia patients.
Mendivil-Perez M; Velez-Pardo C; Quiroz-Duque LM; Restrepo-Rincon A; Valencia-Zuluaga NA; Jimenez-Del-Rio M
Biometals; 2022 Aug; 35(4):741-758. PubMed ID: 35635647
[TBL] [Abstract] [Full Text] [Related]
3. Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo.
Mendivil-Perez M; Jimenez-Del-Rio M; Velez-Pardo C
Med Oncol; 2022 May; 39(7):109. PubMed ID: 35578067
[TBL] [Abstract] [Full Text] [Related]
4. Optic neuropathy associated with GVHD after bone marrow allogeneic hematopoietic stem cell transplantation for B-Acute lymphoblastic leukemia: case report.
Wang B; Jiang F; Wang X
BMC Ophthalmol; 2022 Mar; 22(1):97. PubMed ID: 35232408
[TBL] [Abstract] [Full Text] [Related]
5. The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression.
Rohrbacher L; Brauchle B; Ogrinc Wagner A; von Bergwelt-Baildon M; Bücklein VL; Subklewe M
Front Immunol; 2021; 12():608625. PubMed ID: 33790890
[TBL] [Abstract] [Full Text] [Related]
6. Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols.
Kroczka S; Stepien K; Witek-Motyl I; Kwiecinska K; Kapusta E; Biedron A; Skorek P; Skoczen S
BMC Cancer; 2021 Feb; 21(1):150. PubMed ID: 33568096
[TBL] [Abstract] [Full Text] [Related]
7. Selective ERBB2 and BCL2 Inhibition Is Synergistic for Mitochondrial-Mediated Apoptosis in MDS and AML Cells.
Kam AYF; Piryani SO; Lee CL; Rizzieri DA; Spector NL; Sarantopoulos S; Doan PL
Mol Cancer Res; 2021 May; 19(5):886-899. PubMed ID: 33514658
[TBL] [Abstract] [Full Text] [Related]
8. Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation.
Becker JS; Fathi AT
Curr Cancer Drug Targets; 2020; 20(7):490-500. PubMed ID: 32329690
[TBL] [Abstract] [Full Text] [Related]
9. Neutrophil elastase-mediated proteolysis of the tumor suppressor p200 cux1 promotes cell proliferation and inhibits cell differentiation in APL.
Yu L; Zhong L; Xiong L; Dan W; Li J; Ye J; Wan P; Luo X; Chu X; Liu C; He C; Mu F; Liu B
Life Sci; 2020 Feb; 242():117229. PubMed ID: 31887298
[TBL] [Abstract] [Full Text] [Related]
10. A prospective, randomized study to compare the combination of imatinib and cytarabine versus imatinib alone in newly diagnosed patients with chronic phase chronic myeloid leukemia.
Samal P; Chakrabarti P; Nath UK
Indian J Cancer; 2019; 56(3):211-215. PubMed ID: 31389383
[TBL] [Abstract] [Full Text] [Related]
11. Duvelisib: a new phosphoinositide-3-kinase inhibitor in chronic lymphocytic leukemia.
Frustaci AM; Tedeschi A; Deodato M; Zamprogna G; Cairoli R; Montillo M
Future Oncol; 2019 Jul; 15(19):2227-2239. PubMed ID: 31137964
[TBL] [Abstract] [Full Text] [Related]
12. Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib.
Krause G; Hassenrück F; Hallek M
Drug Des Devel Ther; 2018; 12():2577-2590. PubMed ID: 30174412
[TBL] [Abstract] [Full Text] [Related]
13. Laser assisted synthesis of inorganic fullerene like MoS
Panchu SJ; Dhani S; Chuturgoon A; Moodley MK
J Photochem Photobiol B; 2018 Oct; 187():10-17. PubMed ID: 30081215
[TBL] [Abstract] [Full Text] [Related]
14. Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.
Sharma S; Čermáková K; De Rijck J; Demeulemeester J; Fábry M; El Ashkar S; Van Belle S; Lepšík M; Tesina P; Duchoslav V; Novák P; Hubálek M; Srb P; Christ F; Řezáčová P; Hodges HC; Debyser Z; Veverka V
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7053-E7062. PubMed ID: 29997176
[TBL] [Abstract] [Full Text] [Related]
15. Cross-linking by epichlorohydrin and diepoxybutane correlates with cytotoxicity and leads to apoptosis in human leukemia (HL-60) cells.
Le PM; Silvestri VL; Redstone SC; Dunn JB; Millard JT
Toxicol Appl Pharmacol; 2018 Aug; 352():19-27. PubMed ID: 29792945
[TBL] [Abstract] [Full Text] [Related]
16. A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations.
Litichevskiy L; Peckner R; Abelin JG; Asiedu JK; Creech AL; Davis JF; Davison D; Dunning CM; Egertson JD; Egri S; Gould J; Ko T; Johnson SA; Lahr DL; Lam D; Liu Z; Lyons NJ; Lu X; MacLean BX; Mungenast AE; Officer A; Natoli TE; Papanastasiou M; Patel J; Sharma V; Toder C; Tubelli AA; Young JZ; Carr SA; Golub TR; Subramanian A; MacCoss MJ; Tsai LH; Jaffe JD
Cell Syst; 2018 Apr; 6(4):424-443.e7. PubMed ID: 29655704
[TBL] [Abstract] [Full Text] [Related]
17. Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines.
Yao C; Zhang G; Walker A; Zhao KY; Li Y; Lyu L; Tang Y; Ru P; Jones D; Zhao W
Leuk Res; 2017 Sep; 60():129-134. PubMed ID: 28818808
[TBL] [Abstract] [Full Text] [Related]
18. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
[TBL] [Abstract] [Full Text] [Related]
19. Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic leukemia HL-60 Cells.
Li Z; Guo JR; Chen QQ; Wang CY; Zhang WJ; Yao MC; Zhang W
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335578
[TBL] [Abstract] [Full Text] [Related]
20. PI3K-δ inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells.
Safaroghli-Azar A; Bashash D; Sadreazami P; Momeny M; Ghaffari SH
Anticancer Drugs; 2017 Apr; 28(4):436-445. PubMed ID: 28125433
[TBL] [Abstract] [Full Text] [Related]
[Next]
